首页> 外文期刊>Journal of Medical Microbiology: An Official Journal of the Pathological Society of Great Britain and Ireland >Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica
【24h】

Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica

机译:在哥斯达黎加一家主要医院中,带有blaIMP和blaVIM金属β-内酰胺酶的耐碳青霉烯的铜绿假单胞菌分离株占优势

获取原文
获取外文期刊封面目录资料

摘要

This study aimed to assess the molecular basis of the resistance to carbapenems in clinical isolates of Pseudomonas aeruginosa recovered from a tertiary-level health facility in San José, Costa Rica. A total of 198 non-duplicated isolates were evaluated for their susceptibility to β-lactams, aminoglycosides and fluoroquinolones. The production of metallo-β-lactamases (MBLs), the presence of MBL encoding genes (bla IMP, bla VIM and bla GIM-1) and the occurrence of these genes within class 1 integrons were investigated. In addition, an ERIC2 PCR fingerprinting method was used to elucidate the distribution of the detected MBL genes within the strain collection. Of the 198 isolates tested, 125 (63.1 %) were categorized as carbapenem-resistant. The majority (88.8 %) of the carbapemen-resistant isolates also showed resistance to ceftazidime, cefepime, aztreonam, ticarcillin/clavulanic acid, amikacin, gentamicin, tobramycin, ciprofloxacin and gatifloxacin. Among the carbapenem-resistant isolates, 102 (81.6 %) showed MBL activity. Strikingly, both bla IMP and bla VIM genes were simultaneously detected in most (94.1 %) of the 102 MBL producers. Five carbapenem-resistant MBL producers were positive only for bla IMP genes. Almost 70 % of the isolates examined harboured the intI1 gene, accompanied by the sul1 and qacEΔ1 genes in 136 (99 %) and 122 (89 %) isolates, respectively. The majority (94.4 %) of the carbapenem-resistant isolates carried the intI1 gene, in contrast to 26 % of the carbapenem-susceptible isolates. Ninety-three out of 96 (96.9 %) isolates carrying both bla IMP and bla VIM genes also harboured the intI1, sul1 and qacEΔ1 genes. Gene cassettes from carbapenem-susceptible and MBL-negative carbapenem-resistant isolates encoded aminoglycoside-resistance enzymes (aadA2, aadA4 and aadA6) as well as orfD and qacF genes. RAPD analysis distributed 126 of the isolates in 29 clusters. Eighty of the 90 bla IMP + bla VIM + isolates were sorted into 16 different clusters, suggesting that the bla IMP and bla VIM genes detected were located within a genetic element capable of lateral transfer. Carbapenem-resistant MBL-positive isolates were recovered from almost all hospital wards and were over-represented in samples obtained from the surgical emergency and intensive care therapy units. Remarkably, three carbapenem-resistant isolates, exhibiting MBL activity and carrying both bla IMP and bla VIM genes, were recovered from outpatients. Sequence analysis of both bla genes in various isolates revealed that they correspond to the alleles bla IMP-18 and bla VIM-2. To our knowledge, this is the first report of the combination of two metallo-β-lactamases encoded by the bla IMP-18 and bla VIM-2 genes in P. aeruginosa.
机译:这项研究的目的是评估从哥斯达黎加圣何塞的一家三级卫生机构回收的铜绿假单胞菌临床分离株对碳青霉烯类药物的抗性的分子基础。总共评估了198个非重复分离株对β-内酰胺类,氨基糖苷类和氟喹诺酮类药物的敏感性。研究了金属β-内酰胺酶(MBL)的产生,MBL编码基因(bla IMP,bla VIM和bla GIM-1)的存在以及这些基因在1类整合素中的存在。此外,使用ERIC2 PCR指纹图谱方法来阐明检测到的MBL基因在菌株集合中的分布。在测试的198种分离物中,有125种(63.1%)被归为对碳青霉烯类耐药。多数对甲氨蝶呤耐药的菌株(88.8%)也显示出对头孢他啶,头孢吡肟,氨曲南,替卡西林/克拉维酸,阿米卡星,庆大霉素,妥布霉素,环丙沙星和加替沙星的耐药性。在耐碳青霉烯的菌株中,有102种(81.6%)显示出MBL活性。令人惊讶的是,在102个MBL生产者中的大多数(94.1%)中同时检测到bla IMP和bla VIM基因。五个耐碳青霉烯的MBL生产者仅对bla IMP基因呈阳性。检查的分离株中几乎有70%带有intI1基因,并分别在136个分离株(99%)和122个分离株(89%)中带有sul1和qacEΔ1基因。大部分对碳青霉烯耐药的菌株(94.4%)带有intI1基因,而对碳青霉烯敏感的菌株则为26%。携带bla IMP和bla VIM基因的96个菌株中有93个(96.9%)也包含intI1,sul1和qacEΔ1基因。碳青霉烯易感和MBL阴性的碳青霉烯抗性分离株的基因盒编码了氨基糖苷抗性酶(aadA2,aadA4和aadA6)以及orfD和qacF基因。 RAPD分析将126个分离株分布在29个簇中。将90个bla IMP + bla VIM +分离株中的80个分为16个不同的簇,这表明检测到的bla IMP和bla VIM基因位于能够横向转移的遗传元件内。从几乎所有医院病房中回收到对碳青霉烯耐药的MBL阳性分离株,这些分离株在外科急诊和重症监护治疗室获得的样品中含量过高。值得注意的是,从门诊患者中回收了三个具有MBL活性并带有bla IMP和bla VIM基因的碳青霉烯耐药菌株。各种分离物中两个bla基因的序列分析表明,它们分别对应于等位基因bla IMP-18和bla VIM-2。据我们所知,这是铜绿假单胞菌中bla IMP-18和bla VIM-2基因编码的两种金属β-内酰胺酶结合的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号